Israel Englander Trevena Inc Transaction History

Millennium Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.16 - $0.39 $99,272 - $241,977	-620,455 Reduced 31.78%	1,332,140 $204,000
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.5 $390,519 - $976,297	1,952,595 New	1,952,595 $808,000
Q3 2021 Nov 15, 2021	SELL	$1.11 - $1.7 $110,446 - $169,151	-99,501 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $2.9 Million - $4.47 Million	-1,987,834 Reduced 95.23%	99,501 $168,000
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $2.21 Million - $3.66 Million	1,250,265 Added 149.36%	2,087,335 $3.74 Million

Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $1.78 Million - $2.73 Million	837,070 New	837,070 $1.79 Million
Q3 2020 Nov 16, 2020	SELL	$1.53 - $3.13 $24,073 - $49,247	-15,734 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.75 $7,552 - $27,534	15,734 New	15,734 $24,000
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $120,172 - $204,548	-127,843 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$0.51 - $1.88 $63,446 - $233,881	-124,405 Reduced 49.32%	127,843 $199,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $3.47 $155,601 - $1.38 Million	-398,977 Reduced 61.27%	252,248 $108,000
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $492,887 - $797,838	-354,595 Reduced 35.25%	651,225 $1.38 Million
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $766,265 - $1.19 Million	532,129 Added 112.34%	1,005,820 $1.45 Million
Q1 2018 May 15, 2018	BUY	$1.51 - $2.06 $592,531 - $808,354	392,405 Added 482.75%	473,691 $777,000
Q4 2017 Feb 14, 2018	BUY	$1.4 - $2.6 $113,800 - $211,343	81,286	81,286 $130,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $38.2M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.